Target intelligence / Profile preview

Urinary calcium ions

Molecular classification
Other
01

Overview

"Urinary calcium ions" refers to the **amount of calcium ions (Ca2+) excreted in urine**, measured either over a 24-hour period, per unit time, or as a concentration in spot urine samples[5][4]. This is a *physiological output* regulated by kidney function, dietary calcium intake, bone metabolism, and hormones such as parathyroid hormone and vitamin D[7][3]. Calcium handling in the kidney involves filtration at the glomerulus and complex reabsorption in the proximal tubule, thick ascending limb, and distal convoluted tubule, mediated by various channels and transporters such as TRPV5, paracellular claudins, and regulated by calcitropic hormones[2][4][8]. Abnormal urinary calcium excretion (calciuria—either increased or decreased) is an important clinical biomarker for metabolic bone disease, nephrolithiasis, and endocrine disorders. It is not, however, a therapeutic target or molecular receptor but rather an endpoint measurement reflective of upstream molecular and physiological processes. Summary: “Urinary calcium ions” is a measurement, not a drug/protein target, so the entry is incorrect for use as a canonical molecular target. It serves as a clinical biomarker reflecting kidney function and systemic calcium regulation, but is not druggable itself[7][4][8].

Other names
CalciuriaUrinary Ca2+Urinary calcium excretion
02

Mechanism of action

Indirect modulation by drugs that influence renal tubular calcium reabsorption (e.g., thiazides enhance reabsorption via DCT; loop diuretics inhibit NKCC2, decreasing paracellular reabsorption and raising urinary excretion)[7][4]

03

Biological functions

Calcium homeostasisBiomarker of renal tubular handlingIndicator of dietary or metabolic calcium load
04

Disease associations

Nephrolithiasis (kidney stone disease)Hypercalciuria (as a risk factor)Hypocalciuria (in metabolic or genetic disorders)Other (marker in myriad calcium-related disorders)
05

Safety considerations

Not a druggable target; safety concerns relate to *causes* or *consequences* of altered urinary calcium (e.g., kidney stones, hypocalcemia, osteoporosis, secondary effects of diuretics)
06

Interacting drugs

Thiazide diuretics

4 more in the full profile.

07

Biomarkers

Urinary calcium/creatinine ratio24-hour urinary calciumSpot urine calciumFractional excretion of calcium

Beyond the preview

Go deeper on Urinary calcium ions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urinary calcium ions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call